166 related articles for article (PubMed ID: 31857654)
1. SHBG141-161 Domain-Peptide Stimulates GPRC6A-Mediated Response in Leydig and β-Langerhans cell lines.
De Toni L; Guidolin D; De Filippis V; Peterle D; Rocca MS; Di Nisio A; De Rocco Ponce M; Foresta C
Sci Rep; 2019 Dec; 9(1):19432. PubMed ID: 31857654
[TBL] [Abstract][Full Text] [Related]
2. Osteocalcin and Sex Hormone Binding Globulin Compete on a Specific Binding Site of GPRC6A.
De Toni L; Guidolin D; De Filippis V; Tescari S; Strapazzon G; Santa Rocca M; Ferlin A; Plebani M; Foresta C
Endocrinology; 2016 Nov; 157(11):4473-4486. PubMed ID: 27673554
[TBL] [Abstract][Full Text] [Related]
3. GPCR6A Is a Molecular Target for the Natural Products Gallate and EGCG in Green Tea.
Pi M; Kapoor K; Ye R; Smith JC; Baudry J; Quarles LD
Mol Nutr Food Res; 2018 Apr; 62(8):e1700770. PubMed ID: 29468843
[TBL] [Abstract][Full Text] [Related]
4. Uncarboxylated osteocalcin stimulates 25-hydroxy vitamin D production in Leydig cell line through a GPRC6a-dependent pathway.
De Toni L; De Filippis V; Tescari S; Ferigo M; Ferlin A; Scattolini V; Avogaro A; Vettor R; Foresta C
Endocrinology; 2014 Nov; 155(11):4266-74. PubMed ID: 25093461
[TBL] [Abstract][Full Text] [Related]
5. RS 2247911 polymorphism of GPRC6A gene and serum undercarboxylated-osteocalcin are associated with testis function.
Jawich K; Rocca MS; Al Fahoum S; Alhalabi M; Di Nisio A; Foresta C; Ferlin A; De Toni L
J Endocrinol Invest; 2022 Sep; 45(9):1673-1682. PubMed ID: 35482214
[TBL] [Abstract][Full Text] [Related]
6. Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants.
Rueda P; Harley E; Lu Y; Stewart GD; Fabb S; Diepenhorst N; Cremers B; Rouillon MH; Wehrle I; Geant A; Lamarche G; Leach K; Charman WN; Christopoulos A; Summers RJ; Sexton PM; Langmead CJ
PLoS One; 2016; 11(1):e0146846. PubMed ID: 26785252
[TBL] [Abstract][Full Text] [Related]
7. Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues.
Pi M; Kapoor K; Wu Y; Ye R; Senogles SE; Nishimoto SK; Hwang DJ; Miller DD; Narayanan R; Smith JC; Baudry J; Quarles LD
Mol Endocrinol; 2015 Dec; 29(12):1759-73. PubMed ID: 26440882
[TBL] [Abstract][Full Text] [Related]
8. Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.
Pi M; Kapoor K; Ye R; Nishimoto SK; Smith JC; Baudry J; Quarles LD
Endocrinology; 2016 May; 157(5):1866-80. PubMed ID: 27007074
[TBL] [Abstract][Full Text] [Related]
9. GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo.
Pi M; Wu Y; Quarles LD
J Bone Miner Res; 2011 Jul; 26(7):1680-3. PubMed ID: 21425331
[TBL] [Abstract][Full Text] [Related]
10. GPRC6A: Jack of all metabolism (or master of none).
Pi M; Nishimoto SK; Quarles LD
Mol Metab; 2017 Feb; 6(2):185-193. PubMed ID: 28180060
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of uncarboxylated osteocalcin on buffalo Leydig cell steroidogenesis.
Bharath Kumar BS; Mallick S; Manjunathachar HV; Shashank CG; Sharma A; Nagoorvali D; Soren S; Jadhav VG; Pandita S
Vet Res Commun; 2024 Jun; 48(3):1423-1433. PubMed ID: 38305958
[TBL] [Abstract][Full Text] [Related]
12. Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.
Pi M; Nishimoto SK; Darryl Quarles L
Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33474566
[TBL] [Abstract][Full Text] [Related]
13. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks.
Pi M; Quarles LD
Endocrinology; 2012 May; 153(5):2062-9. PubMed ID: 22374969
[TBL] [Abstract][Full Text] [Related]
14. Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.
Ye R; Pi M; Nooh MM; Bahout SW; Quarles LD
Mol Pharmacol; 2019 May; 95(5):563-572. PubMed ID: 30894404
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
[TBL] [Abstract][Full Text] [Related]
16. GPRC6A mediates the non-genomic effects of steroids.
Pi M; Parrill AL; Quarles LD
J Biol Chem; 2010 Dec; 285(51):39953-64. PubMed ID: 20947496
[TBL] [Abstract][Full Text] [Related]
17. Computationally identified novel agonists for GPRC6A.
Pi M; Kapoor K; Ye R; Hwang DJ; Miller DD; Smith JC; Baudry J; Quarles LD
PLoS One; 2018; 13(4):e0195980. PubMed ID: 29684031
[TBL] [Abstract][Full Text] [Related]
18. The L-α-amino acid receptor GPRC6A is expressed in the islets of Langerhans but is not involved in L-arginine-induced insulin release.
Smajilovic S; Clemmensen C; Johansen LD; Wellendorph P; Holst JJ; Thams PG; Ogo E; Bräuner-Osborne H
Amino Acids; 2013 Feb; 44(2):383-90. PubMed ID: 22714012
[TBL] [Abstract][Full Text] [Related]
19. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
[TBL] [Abstract][Full Text] [Related]
20. Undercarboxylated, But Not Carboxylated, Osteocalcin Suppresses TNF-α-Induced Inflammatory Signaling Pathway in Myoblasts.
Park D; Kim DY; Byun MR; Hwang H; Ko SH; Baek JH; Baek K
J Endocr Soc; 2022 Aug; 6(8):bvac084. PubMed ID: 35702666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
